| 000 | 00691 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250511161313.0 | ||
| 264 | 0 | _c19761203 | |
| 008 | 197612s 0 0 eng d | ||
| 022 | _a0048-5764 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaplan, S A | |
| 245 | 0 | 0 |
_aOverview on bioavailability and bioequivalence. _h[electronic resource] |
| 260 |
_bPsychopharmacology bulletin _cOct 1976 |
||
| 300 |
_a50-1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xmetabolism |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 773 | 0 |
_tPsychopharmacology bulletin _gvol. 12 _gno. 4 _gp. 50-1 |
|
| 999 |
_c980519 _d980519 |
||